Finance entity
All 4 tracked stories fall under one category: earnings. Scott Keeney is the most frequent co-covered peer, appearing in 2 of the 4 tracked stories. Each story carries 6.5 original sources on average, compared with 2.8 for the broader beat in this window.
Last mentioned: 2d ago
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 4 tracked stories fall under one category: earnings. Scott Keeney is the most frequent co-covered peer, appearing in 2 of the 4 tracked stories. Each story carries 6.5 original sources on average, compared with 2.8 for the broader beat in this window. The 169-day window averages about 0.2 stories each week. At 5.8, the average consequence score sits below the same-window beat average of 6.3. nLIGHT appears in 4 tracked Finance stories published from February 27, 2026 through August 14, 2026.
Computed from the 4 stories linked to this entity, with beat comparisons drawn from all 3506 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering nLIGHT. Shared-story counts are live from our verified record — not editorial picks.
MP Materials and Maravai Q2 2026 transcripts released
Call transcripts were published for the rare-earth and life-science companies.
Acacia Research Q2 2026 Earnings Call
Record $114.6M revenue from IP licensing settlement; Life Sciences write-down disclosed.
Q2 2026 earnings show Acacia Research's record $114.6M IP-settlement revenue countered by a Life Sciences write-down, while Dutch Bros grew 32.5%. Datadog, MP Materials, and Maravai add cloud, rare-earth, and biotech signals for investors.
Source: Yahoo! News · Fool
nLIGHT (LASR) has reported a significant improvement in profitability following its strategic decision to exit the commodity industrial fiber laser market. The company is successfully pivoting toward high-margin Aerospace, Defense, and Additive Manufacturing sectors, driving shares toward recent highs.
Source: finance.yahoo.com · insidermonkey.com
Shares of agilon health (AGL) and nLIGHT (LASR) faced significant downward pressure on March 12, 2026, as investors reassessed valuation following recent earnings reports and insider activity. While agilon struggles with persistent medical cost trends, nLIGHT is navigating executive share sales and institutional exits.
A massive wave of Q4 2025 earnings reports reveals a corporate landscape aggressively pivoting toward recurring revenue models while navigating significant tariff and inflationary headwinds. Key performers in FinTech, SaaS, and Defense are demonstrating strong operating leverage despite localized consumer softness.
nLIGHT is linked from 4 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
